IMS: The big cities in China are the first choice for the strategy of multinational pharmaceutical companies
My stake betting appstake sports betting appRelease time: 2010-05-20 & nbsp & nbsp & nbsp Source:
The world's leading pharmaceutical information provider IMS Health thinks，China's big cities dominate the Chinese pharmaceutical market，Pharmaceutical companies must develop a special sales strategy，To adapt to the development of such markets。
IMS Healthy Vice President Jan-Willem Eleveld Say a long time ago，"China's top 120 cities occupy 75%of China's pharmaceutical market，Therefore, for multinational pharmaceutical companies，It is necessary to occupy these city markets first。”
He thinks，The main challenge facing these large cities markets is，What products should companies focus on it，What kind of city should I choose，What kind of business model should we take to get the maximum profit。
IMS prediction，stake betting appIn the next few years，China's pharmaceutical market will continue to maintain a growth rate of more than 25%。Eleveld thinks，The strong development momentum of the Chinese market，In the future, the incidence of the incidence of tumors and other chronic diseases will increase，Population growth，Comprehensive effects of changes in people's lifestyles。He said，China has a better infrastructure，People’s lives are gradually becoming rich，enable them to see a doctor more freely。
IMS has predicted，In the next 5 years，16 "Medical Emerging Markets" except China，It will also play a huge role in the growth of the global pharmaceutical market，to 2013，These countries will contribute 48%of the annual market growth rate，and 37%in 2009。Last My stake betting appyear，China has become My stake betting appthe second largest contributor to the global market growth rate，second only to the United States。2009，Drug sales of Chinese hospital channels reached 35.6 billion US dollars，annual growth rate of 27%。
According to McKinsey Forecast，to 2014，China will spend 521 billion U.S. dollars in medical care，2016 reached $ 659 billion。This is for multinational pharmaceutical companies，It is undoubtedly full of temptation。
IMS Healthy Vice President Jan-Willem Eleveld Say a long time ago，"China's top 120 cities occupy 75%of China's pharmaceutical market，Therefore, for multinational pharmaceutical companies，It is necessary to occupy these city markets first。”
He thinks，The main challenge facing these large cities markets is，What products should companies focus on it，What kind of city should I choose，What kind of business model should we take to get the maximum profit。
IMS prediction，stake betting appIn the next few years，China's pharmaceutical market will continue to maintain a growth rate of more than 25%。Eleveld thinks，The strong development momentum of the Chinese market，In the future, the incidence of the incidence of tumors and other chronic diseases will increase，Population growth，Comprehensive effects of changes in people's lifestyles。He said，China has a better infrastructure，People’s lives are gradually becoming rich，enable them to see a doctor more freely。
IMS has predicted，In the next 5 years，16 "Medical Emerging Markets" except China，It will also play a huge role in the growth of the global pharmaceutical market，to 2013，These countries will contribute 48%of the annual market growth rate，and 37%in 2009。Last My stake betting appyear，China has become My stake betting appthe second largest contributor to the global market growth rate，second only to the United States。2009，Drug sales of Chinese hospital channels reached 35.6 billion US dollars，annual growth rate of 27%。
According to McKinsey Forecast，to 2014，China will spend 521 billion U.S. dollars in medical care，2016 reached $ 659 billion。This is for multinational pharmaceutical companies，It is undoubtedly full of temptation。
